Table 2.
Prevalence and Incidence of Cancer-Related Fatigue
Assessment | Prevalence | Incidence | ||
---|---|---|---|---|
Frequency | % | Frequency | % | |
Baseline | 30/304 | 9.9 | 30/304 | 9.9 |
Post-Tx | 67/304 | 22.0 | 50/304 | 16.4 |
6-Months Post-Tx | 26/282 | 9.2 | 11/304 | 3.6 |
42-Months Post-Tx | 29/222 | 13.1 | 10/304 | 3.3 |
Tx indicates treatment.